Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

SEC Filings

RSS RSS Feeds
Form 10-K
MERIDIAN BIOSCIENCE INC filed this Form 10-K on 11/29/2018
Document Outline
Entire Document (3432 KB)
Subdocument 1 - 10-K - FORM 10-K
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - N/A
Page 3 - N/A
Page 4 - illumigene and illumipro, is being rebranded under the tradename Alethia. References to Alethia thro
Page 5 - Reportable Segments
Page 6 - N/A
Page 7 - Market Trends
Page 8 - Sales, Marketing and Distribution
Page 9 - Research and Development
Page 10 - Government Regulation
Page 11 - Life Science Segment
Page 12 - Competition
Page 13 - Environmental
Page 14 - We may be unable to successfully integrate operations or to achieve expected cost savings from acqui
Page 15 - We could be adversely affected by health care reform legislation.
Page 16 - Efforts to reduce the U.S. federal deficit could adversely affect our results of operations.
Page 17 - Intense competition could adversely affect our profitability.
Page 18 - Risks Affecting our Manufacturing Operations
Page 19 - Significant interruptions in production at our principal manufacturing facilities and/or third-party
Page 20 - We depend on sole-source suppliers for certain critical raw materials, components and finished produ
Page 21 - Risks Related to Intellectual Property and Product Liability
Page 22 - Other Risks Affecting Our Business
Page 23 - Breaches of our information technology systems could have a material adverse effect on our operation
Page 24 - Risks Related to Our Common Stock
Page 25 - There can be no assurance that we will continue to pay dividends.
Page 26 - N/A
Page 27 - N/A
Page 28 - Market Information
Page 29 - N/A
Page 30 - Results of Operations:
Page 31 - Update on Lead Testing
Page 32 - USE OF NON-GAAP MEASURES
Page 33 - N/A
Page 34 - REVENUE OVERVIEW
Page 35 - Revenue Overview- By Product Platform/Type
Page 36 - Diagnostics Products
Page 37 - Life Science Products
Page 38 - Operating Expenses -
Page 39 - Operating Expenses -
Page 40 - Life Science
Page 41 - Liquidity and Capital Resources:
Page 42 - N/A
Page 43 - Capital Resources
Page 44 - Other Commitments and Off-Balance Sheet Arrangements:
Page 45 - Recent Accounting Pronouncements:
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 50 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 51 - N/A
Page 52 - CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
Page 53 - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (dollar amounts in thousands)
Page 54 - CONSOLIDATED STATEMENTS OF CASH FLOWS (dollar amounts in thousands)
Page 55 - CONSOLIDATED BALANCE SHEETS (dollar amounts in thousands)
Page 56 - CONSOLIDATED BALANCE SHEETS (dollar amounts in thousands)
Page 57 - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (dollar and share amounts in thousands, except per sh
Page 58 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 59 - N/A
Page 60 - N/A
Page 61 - N/A
Page 62 - N/A
Page 63 - N/A
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - N/A
Page 68 - N/A
Page 69 - N/A
Page 70 - N/A
Page 71 - N/A
Page 72 - N/A
Page 73 - N/A
Page 74 - N/A
Page 75 - N/A
Page 76 - N/A
Page 77 - N/A
Page 78 - N/A
Page 79 - N/A
Page 80 - DIRECTORS
Page 81 - EXHIBIT
Page 82 - N/A
Page 83 - N/A
Page 84 - N/A
Page 85 - N/A
Page 86 - N/A
Subdocument 2 - EX-10.7 - EX-10.7
Page 1 - Exhibit 10.7
Page 2 - 3. Forfeiture of Restricted Units.
Page 3 - 6. Voting and Other Rights. The Grantee will not have any rights of a shareholder of the Company wit
Page 4 - 15. Section 409A of the Code. It is intended that the Restricted Units shall be exempt from the appl
Page 5 - 21. Language. If the Grantee receives this Agreement or any other document related to the Plan trans
Subdocument 3 - EX-10.10.10 - EX-10.10.10
Page 1 - Exhibit 10.10.10
Page 2 - N/A
Page 3 - N/A
Subdocument 4 - EX-21 - EX-21
Page 1 - N/A
Subdocument 5 - EX-23 - EX-23
Page 1 - N/A
Subdocument 6 - EX-31.1 - EX-31.1
Page 1 - N/A
Subdocument 7 - EX-31.2 - EX-31.2
Page 1 - N/A
Subdocument 8 - EX-32 - EX-32
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer